BioHealth News Archive
Baltimore startup wins $500,000 grant from Johnson & Johnson – Baltimore Business Journal
Baltimore-based Glyscend Inc. was awarded one of three $500,000 research grants from Johnson & Johnson Innovation LLC and its research arm Janssen as part…
Read More
HTG Molecular Diagnostics (HTGM), QIAGEN (QGEN) Unit to Develop NGS-Based Diagnostics Solution
HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) and QIAGEN Manchester Limited, a wholly owned subsidiary of QIAGEN N.V. (Nasdaq: QGEN). This Agreement creates a framework…
Read More
Deloitte Announces 2016 North America Technology Fast 500™ Rankings
Deloitte today released the 2016 Technology Fast 500, an annual ranking of the fastest growing North American companies in the technology, media, telecommunications, life…
Read More
MedImmune completes out-licensing agreement with Allergan for MEDI2070
AstraZeneca today announced the completion of the licensing agreement between MedImmune, its global biologics research and development arm, and Allergan plc, for the global…
Read More
2016 Startup Census – Fosterly
Calling all innovators, startups, and entrepreneurs: join us in participating in the first-ever #FosterlyCensus -- a region-wide, community project gathering information and statistics about…
Read More
California remains a national force in life sciences – The San Diego Union-Tribune
California, the nation’s birthplace of biotechnology, continues to add jobs in that sector and the life sciences in general, a trade association reported Wednesday. While…
Read More
Taking a BioHealth Company Global Tickets, Wed, Nov 30, 2016 at 11:30 AM
International Trade - The Basics for Bio & Technology Companies Attend this lunch-and-learn event to hear global industry experts discuss how Maryland companies can…
Read More
Emergent BioSolutions (EBS), Integrated BioTherapeutics Enter Equine-Based Hyperimmunoglobulin Licensing Agreement
Integrated BioTherapeutics (IBT) announced today that it has entered into an exclusive worldwide license agreement with Emergent BioSolutions Inc. (NYSE: EBS) whereby Emergent will…
Read More
17th Annual NIH SBIR/STTR Conference – Ag Sprint
OCTOBER 27, 2015 @ 8:00 AM - OCTOBER 29, 2015 @ 5:00 PM Join us for the 17th Annual National Institutes of Health Small…
Read More
CRISPR gene-editing tested in a person for the first time
A Chinese group has become the first to inject a person with cells that contain genes edited using the revolutionary CRISPR–Cas9 technique. On 28…
Read More
Maryland’s Rockville Innovation Center Takes Aim at Cybersecurity
As the IoT reels from and struggles with ongoing security issues stemming from DDoS and botnet and SSH and DNS and innumerable other interrelated…
Read More
AT&T Gives $25,000 to MdBio Foundation for STEM Education in Maryland
A $25,000 contribution from AT&T will help the MdBio Foundation boost science, technology, engineering and math (STEM) education in Maryland. The contribution supports MdBio…
Read More
Roche launches cancer immunotherapy research network – Fox News
Roche has launched a global cancer immunotherapy Centers of Research Excellence network, saying it will invest up to 100 million Swiss francs ($100.3 million)…
Read More
Emergent Bio and Integrated BioTherapeutics team up to develop hyperimmunoglobulin for Filovirus-associated hemorrhagic fever – Emergent BioSolutions Inc. (NYSE:EBS) | Seeking Alpha
Emergent BioSolutions (EBS -1.9%) and Integrated BioTherapeutics enter into a joint research, development and manufacturing collaboration focused on an equine-based hyperimmunoglobulin for the treatment…
Read More
Corporate Needs Broadcast Webinar Series
Learn what the corporates are thinking. This webinar series highlights the technical and scouting needs of our Corporate Selection Committee for the University Startups…
Read More